We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

176 hedge funds and large institutions have $72.4M invested in Definium Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $5.21M | Put options by funds: $2.36M

54% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 35

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

1% more funds holding

Funds holding: 174 → 176 (+2)

0.05% less ownership

Funds ownership: 0.87% → 0.82% (-0.05%)

31% less capital invested

Capital invested by funds: $105M → $72.4M (-$32.4M)

Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
54
Reduced
35
Closed
29
Calls
$5.21M
Puts
$2.36M
Net Calls
+$2.85M
Net Calls Change
+$1.65M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$4.69M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.96M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.68M
4
BB
Busey Bank
Illinois
+$918K
5
BlackRock
BlackRock
New York
+$816K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$1.68M
2
MI
MMCAP International
Cayman Islands
-$759K
3
Millennium Management
Millennium Management
New York
-$673K
4
Simplex Trading
Simplex Trading
Illinois
-$362K
5
SC
Shay Capital
New York
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWP
76
Stratos Wealth Partners
Ohio
$46K – – –
CAG
77
Csenge Advisory Group
Florida
$42K -$5.33K -167 -17%
APA
78
American Portfolios Advisors
New York
$41.4K – – –
HNB
79
Huntington National Bank
Ohio
$41K -$63.8K -2,000 -50%
CG
80
Cutler Group
California
$41K -$2.39K -75 -4%
Simplex Trading
81
Simplex Trading
Illinois
$38K -$362K -11,350 -86%
IWM
82
IHT Wealth Management
Illinois
$38K -$5.33K -167 -8%
PAMS
83
Pictet Asset Management (Switzerland)
Switzerland
$38K – – –
PAG
84
Private Advisor Group
New Jersey
$36K -$74K -2,320 -58%
AIP
85
Ameritas Investment Partners
Nebraska
$35K – – –
CCA
86
Conservest Capital Advisors
Pennsylvania
$33K +$543 +17 +1%
BCM
87
Bayesian Capital Management
New York
$33K +$50.2K +1,572 New
T. Rowe Price Associates
88
T. Rowe Price Associates
Maryland
$32K -$12.4K -387 -20%
KJHP
89
K.J. Harrison & Partners
Ontario, Canada
$30K – – –
Prudential Financial
90
Prudential Financial
New Jersey
$28K -$5.36K -168 -11%
RFC
91
Regions Financial Corp
Alabama
$28K +$42.5K +1,333 New
Fisher Asset Management
92
Fisher Asset Management
Washington
$28K +$42.8K +1,342 New
Carson Wealth (CWM LLC)
93
Carson Wealth (CWM LLC)
Nebraska
$27K +$41.8K +1,309 New
Mackenzie Financial
94
Mackenzie Financial
Ontario, Canada
$26K +$575 +18 +1%
HF
95
HRT Financial
New York
$24K +$37.8K +1,183 New
X
96
Xponance
Pennsylvania
$23K +$255 +8 +0.7%
FDCDDQ
97
Federation des caisses Desjardins du Quebec
Quebec, Canada
$22.8K -$223 -7 -0.6%
CAM
98
Close Asset Management
United Kingdom
$22K – – –
TWC
99
TD Waterhouse Canada
Ontario, Canada
$21.8K +$28.5K +893 New
V
100
Veritable
Delaware
$21K – – –
2 3
4
5 6

DFTX Hedge Fund Activity: Q4 2021 in Review

176 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2021, worth a combined $72.4M — down 31% from $105M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new DFTX positions and 29 closed out — a net gain of 8 holders — while 54 added to existing stakes and 35 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.69M. The largest seller was Goldman Sachs, cutting an estimated $1.68M.

  • 176 institutional investors held Definium Therapeutics (DFTX) as of Q4 2021, up from 174 in Q3 2021.
  • Funds reported $72.4M of Definium Therapeutics stock for Q4 2021, down 31% quarter-over-quarter.
  • 37 funds opened new Definium Therapeutics positions in Q4 2021 and 29 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q4 2021 was Morgan Stanley, an estimated $4.69M added.
  • The largest Definium Therapeutics seller in Q4 2021 was Goldman Sachs, an estimated $1.68M sold.

Based on aggregated 13F filings for Q4 2021.